OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Advanced
Search
18
Results
Show all
Save search
Copy query
Show results for
Unknown
(18)
Publication Date
Release Date
2022
(5)
2023
(3)
2021
(3)
2025
(1)
2024
(1)
2020
(1)
2019
(1)
2018
(1)
2017
(1)
2016
(1)
Previous
page
1 / 2
You're on page
1
page
2
Next
page
Sort
by:
Relevance
Page size
10
Projected Impact of Nonpharmacologic Management of Stage 1 Hypertension Among Lower-Risk US Adults.
Not available
S-EPMC11254541
|
biostudies-literature
Cite
Racial Disparities and Diagnosis-to-Treatment Time Among Patients Diagnosed with Breast Cancer in South Carolina.
Not available
S-EPMC8272729
|
biostudies-literature
Cite
Society of Surgical Oncology-American Society for Radiation Oncology-American Society of Clinical Oncology Consensus Guideline on Margins for Breast-Conserving Surgery With Whole-Breast Irradiation in Ductal Carcinoma in Situ.
Not available
S-EPMC5070537
|
biostudies-literature
Cite
The Altered Transcriptome and DNA Methylation Profiles of Docetaxel Resistance in Breast Cancer PDX Models.
Not available
S-EPMC7616969
|
biostudies-literature
Cite
Patient Selection for Intensive Blood Pressure Management Based on Benefit and Adverse Events.
Not available
S-EPMC8068761
|
biostudies-literature
Cite
A novel approach for selecting combination clinical markers of pathology applied to a large retrospective cohort of surgically resected pancreatic cysts.
Not available
S-EPMC5201184
|
biostudies-literature
Cite
The Transcriptomic Portrait of Locally Advanced Breast Cancer and Its Prognostic Value in a Multi-Country Cohort of Latin American Patients.
Not available
S-EPMC9007037
|
biostudies-literature
Cite
HNF4A and GATA6 Loss Reveals Therapeutically Actionable Subtypes in Pancreatic Cancer.
Not available
S-EPMC9511995
|
biostudies-literature
Cite
Machine Learning Identifies Stemness Features Associated with Oncogenic Dedifferentiation.
Not available
S-EPMC5902191
|
biostudies-literature
Cite
Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial.
Not available
S-EPMC8830904
|
biostudies-literature
Cite
Previous
page
1 / 2
You're on page
1
page
2
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets